Invasive pneumococcal infections in Denmark from 1995 to 1999: Epidemiology, serotypes, and resistance

被引:66
作者
Konradsen, HB [1 ]
Kaltoft, MS [1 ]
机构
[1] Statens Serum Inst, Div Microbiol, Dept Resp Infect Meningitis & STIs, Streptococcus Unit, DK-2300 Copenhagen S, Denmark
关键词
D O I
10.1128/CDLI.9.2.358-365.2002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Danish nationwide surveillance data on invasive pneumococcal disease from the 5-year period from 1995 to 1999, including 5,452 isolates, are presented and described. Annual overall incidence rates, serotype distribution, and antimicrobial susceptibility patterns of the isolates were monitored. Major changes in the total annual incidence rate from 27/100,000 in 1996 to 17/100,000 in 1999 and a significant change in the proportion of invasive isolates belonging to types 1 and 12F were observed. The serotype coverage rate by the 23-valent polysaccharide vaccine among the elderly was 92.9%, and the serotype coverage rate by the 7-, 9-, and 11-valent pneumococcal conjugate vaccines among children less than 2 years old were 71.7, 75.2, and 81.4%, respectively. Invasive isolates with reduced susceptibility to penicillin or erythromycin increased from 1995 to 1999, with a high proportion of the penicillin-nonsusceptible invasive isolates originating from people 60 years old or older (57.0%). These observations underline the importance of adequate surveillance systems of invasive pneumococcal disease to introduce and maintain national vaccine strategies and adequate antibiotic policy.
引用
收藏
页码:358 / 365
页数:8
相关论文
共 29 条
[1]  
[Anonymous], STREPTOCOCCUS PNEUMO
[2]   Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].
Black, S ;
Shinefield, H ;
Fireman, B ;
Lewis, E ;
Ray, P ;
Hansen, JR ;
Elvin, L ;
Ensor, KM ;
Hackell, J ;
Siber, G ;
Malinoski, F ;
Madore, D ;
Chang, I ;
Kohberger, R ;
Watson, W ;
Austrian, R ;
Edwards, K .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195
[3]   The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the centers for disease control and prevention's pneumococcal sentinel surveillance system [J].
Butler, JC ;
Hofmann, J ;
Cetron, MS ;
Elliott, JA ;
Facklam, RR ;
Breiman, RF ;
Camp, C ;
Charache, P ;
Dern, R ;
Jackson, M ;
Hadley, WK ;
HoppeBauer, J ;
Jacobs, MR ;
Schreiber, J ;
Boxerbaum, B ;
Menuey, BC ;
Tyler, PG ;
Monahan, J ;
Moore, H ;
Siegel, JD ;
Sherer, D ;
Rogers, P ;
Welch, D ;
Fine, D ;
Radike, J ;
Fiore, A ;
Alexander, M ;
Deaver, K .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (05) :986-993
[4]   SEROTYPE DISTRIBUTION OF STREPTOCOCCUS-PNEUMONIAE INFECTIONS AMONG PRESCHOOL-CHILDREN IN THE UNITED-STATES, 1978-1994 - IMPLICATIONS FOR DEVELOPMENT OF A CONJUGATE VACCINE [J].
BUTLER, JC ;
BREIMAN, RF ;
LIPMAN, HB ;
HOFMANN, J ;
FACKLAM, RR .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :885-889
[5]   Epidemiology of infection - Pneumococci causing invasive disease in Britain 1982-1990 [J].
Colman, G ;
Cooke, EM ;
Cookson, BD ;
Cooper, PG ;
Efstratiou, A ;
George, RC .
JOURNAL OF MEDICAL MICROBIOLOGY, 1998, 47 (01) :17-27
[6]   Temporary increase in incidence of invasive infection due to Streptococcus pneumoniae in the Netherlands [J].
de Neeling, AJ ;
van Pelt, W ;
Hol, C ;
Ligtvoet, EEJ ;
Sabbe, LJM ;
Bartelds, A ;
van Embden, JDA .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (06) :1579-1580
[7]   The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known [J].
Fedson, DS ;
Anthony, J ;
Scott, G .
VACCINE, 1999, 17 :S11-S18
[8]   Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain:: Update (1990 to 1996) [J].
Fenoll, A ;
Jado, I ;
Vicioso, D ;
Pérez, A ;
Casal, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (12) :3447-3454
[9]  
HAKENBECK R, 1994, KLIN LAB, V3, P230
[10]   Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use, part I [J].
Hausdorff, WP ;
Bryant, J ;
Paradiso, PR ;
Siber, GR .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (01) :100-121